Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial von Kavanaugh, Arthur, van der Heijde, Désirée, McInnes, Iain B., Mease, Philip, Krueger, Gerald G., Gladman, Dafna D., Gómez-Reino, Juan, Papp, Kim, Baratelle, Anna, Xu, Weichun, Mudivarthy, Surekha, Mack, Michael, Rahman, Mahboob U., Xu, Zhenhua, Zrubek, Julie, Beutler, Anna

Volltext

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the ra... von Kavanaugh, Arthur, McInnes, Iain B, Mease, Philip J, Krueger, Gerald G, Gladman, Dafna D, van der Heijde, Désirée, Mudivarthy, Surekha, Xu, Weichun, Mack, Michael, Xu, Zhenhua, Beutler, Anna

Volltext

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety resu... von Kavanaugh, Arthur, McInnes, Iain, Mease, Philip, Krueger, Gerald G., Gladman, Dafna, Gomez‐Reino, Juan, Papp, Kim, Zrubek, Julie, Mudivarthy, Surekha, Mack, Michael, Visvanathan, Sudha, Beutler, Anna

Volltext

Concurrent Oral 6 – Spondylarthropathies [OP40–OP47] von Jadon, Deepak R., Cavill, Charlotte, Waldron, Nicola, Barton, Ann, Korendowych, Eleanor, McHugh, Neil J., Coates, Laura C., Helliwell, Philip S., van der Heijde, Désirée, Emery, Paul, Patra, Kaushik, Lavie, Frederic, Skerrett, Jane, van der Weide, Ingrid, Barlow, Julie, Keat, Andrew, Gladman, Dafna, Kavanaugh, Arthur, Chattopadhyay, Chandrabhusan, Mease, Philip, Krueger, Gerald G., Zrubek, Julie, Beutler, Anna, Hsu, Benjamin, Mudivarthy, Surekha, Mack, Michael, McInnes, Iain B., Kirkham, Bruce, Fitzgerald, Oliver, Robertson, Debbie, Estojak, Joanne, Foehl, Joanne, Molta, Charles, Freundlich, Bruce, Navarro, Federico, Sueiro, Jose Luis Fernandez, Torre Alonso, Juan Carlos, Queiro, Ruben, Gonzalez, Carlos, Gratacos, Jordi, Loza, Eduardo, Linares, Luis, Zarco, Pedro, Juanola, Xavier, Andrés Román Ivorra, Jose, Martín Mola, Emilio, Sanmartí, Raimon, Mulero, Juan, Díaz, Gema, Alfonso, Ejessie, Collantes, Eduardo, Healey, Emma L., Haywood, Kirstie L., Jordan, Kelvin P., Garratt, Andrew M., Packham, Jonathan C.

Volltext

Erratum: Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and sa... von Kavanaugh, Arthur, McInnes, Iain, Mease, Philip, Krueger, Gerald G., Gladman, Dafna, Gomez‐Reino, Juan, Papp, Kim, Zrubek, Julie, Mudivarthy, Surekha, Mack, Michael, Visvanathan, Sudha, Beutler, Anna

Volltext

Golimumab, a New Human Tumor Necrosis Factor a Antibody, Administered Every Four Weeks as a Subcutaneous Injection in Psoriatic Arthritis : Twenty-Four-Week Efficacy and Safety Res... von KAVANAUGH, Arthur, MCLNNES, Iain, VISVANATHAN, Sudha, BEUTLER, Anna, MEASE, Philip, KRUEGER, Gerald G, GLADMAN, Dafna, GOMEZ-REINO, Juan, PAPP, Kim, ZRUBEK, Julie, MUDIVARTHY, Surekha, MACK, Michael

Volltext

Model Selection and Inference von Mudivarthy, Surekha, Rao, M. Bhaskara

Volltext